Washington, D.C.—In the wake of the filing of a lawsuit against fish oil manufacturers over alleged polychlorinated biphenyl (PCB) contamination in their products, the Council for Responsible Nutrition (CRN), based here, released a statement defending the practices of these companies.
Washington, D.C.—Last month, WholeFoods reported on proposed legislation sponsored by Arizona Senator John McCain (R-AZ) that would redefine dietary supplements and place new burdens on the dietary supplement industry. In the weeks that followed, several industry companies and associations responded to the Dietary Supplement Safety Act (DSSA, S3.002) in full force.
Washington, D.C.—Former Presidential candidate, Senator John McCain (R-AZ), has introduced new legislation, the Dietary Supplement Safety Act of 2010, which will amend the current Federal Food, Drug, and Cosmetic Act (FD&C Act). In this bi-partisan bill, co-sponsored by Senator Byron Dorgan (D-ND), McCain seeks “to more effectively regulate dietary supplements that may pose safety risks unknown to consumers.”
Gainesville, FL—Data collected in November/December 2009 by resveratrol supplement maker ReserveAge Organics, based here, offer some illuminating insight into consumers’ attitudes with respect to this popular herb.
Alexandria, VA—Consumers who are concerned about the safety of dietary supplements should pay attention to a new statistic offered by the American Association of Poison Control Centers. According to the U.S. National Poison Data System, dietary supplements caused no deaths in 2008.
New York, NY—WholeFoods reported last month on the U.S. Food and Drug Administration’s (FDA) publication of draft guidelines concerning the distinction between beverages and liquid dietary supplements. Since then, as part of the commentary phase of the FDA guideline process, Ullman, Shapiro and Ullman, LLP have submitted a thorough response statement in opposition to the proposed FDA guidelines.
Boston, MA—A review of relevant data has highlighted some trends in, and pinpointed factors influencing the use of complementary and alternative medicine (CAM) among young people. The study, out of Harvard Medical School and Boston University, tracked available statistics to look for factors influencing CAM use in the pediatric population, or those 18 years old and younger.
In a notice published in the December 4 Federal Register, the Drug Enforcement Administration (DEA) ruled that boldione, desoxymethyltestosterone (DMT) and 19-nor-4,9(10)-androstadienedione will all be classified as anabolic steroids under the Controlled Substances Act.
Chicago, IL—At the end of last year, Ginkgo biloba became a top story as research printed in the Journal of the American Medical Association (JAMA), published here, indicated that the herb did not prevent cognitive decline in older adults. The group came to this conclusion after analyzing data from the Ginkgo Evaluation of Memory (GEM) study conducted between 2000 and 2008.